Kariko, BioNTech leadership to receive Paul Ehrlich and Ludwig Darmstaedter Prize
BioNTech and its scientific team led by Kariko are acclaimed for the research and development of mRNA-based vaccines.
The prize comes with a 120,000 euro reward.
In a statement, the foundation said BioNTech “established a technology platform that is likely to initiate a paradigm shift in some areas of medicine”. “The spectacularly rapid development of a highly effective vaccine against the coronavirus disease COVID-19, which has proven to play a decisive role in the worldwide containment of the SARS-CoV-2 pandemic, has been an outstanding success,” the statement said.